Medication info
Trapen Extended Release Tablets

Trapen Extended Release Tablets

Prescription medicationTabletOral
Ingredient · strength
Tramadol Hydrochloride›75mg / 1 tabletAcetaminophen›325mg / 1 tablet
Manufacturer / importer
Myungmoon Pharmaceutical Co., Ltd.
Appearance
Pale yellow oblong film-coated extended release tablet
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 201209007 · Approved 2012.11.30 · Insurance code 649806190

Summary

Main use
Relief of moderate to severe acute and chronic pain
Who takes it
Adults
Adult dose
Adults: The dose should be adjusted according to the severity of the patient's pain and treatment response. An initial dose of 1 tablet is recommended; thereafter, doses should be spaced at least 12 hours apart, and no more than 4 tablets should be taken per day. Do not use this medicine for longer than necessary. If long-term administration is required due to the nature or severity of the disease, conduct regular monitoring to determine whether treatment should continue. Nausea, vomiting, itching, constipation, dizziness, drowsiness, etc. may occur when taking this medicine; closely monitor the patient's response and adjust treatment appropriately. Older adults: Administer the usual adult dose. However, since the elimination half-life of tramadol increased by 17% when administered orally to older adults aged 75 years and older, administer this medicine at intervals of at least 12 hours. Patients with renal impairment: The safety and efficacy of this medicine in patients with renal impairment have not been established; therefore, its use is not recommended. Patients with hepatic impairment: The safety and efficacy of this medicine in patients with hepatic impairment have not been established; therefore, its use is not recommended.

Ingredients

Manufacturer
Myungmoon Pharmaceutical Co., Ltd.

Efficacy & effects

Relief of moderate to severe acute and chronic pain

  • Acute pain
  • chronic pain
View approved original text

This medication is used for the relief of acute and chronic pain ranging from moderate to severe.

How to take

Adult dose

Adults: The dose should be adjusted according to the severity of the patient's pain and treatment response. An initial dose of 1 tablet is recommended; thereafter, doses should be spaced at least 12 hours apart, and no more than 4 tablets should be taken per day. Do not use this medicine for longer than necessary. If long-term administration is required due to the nature or severity of the disease, conduct regular monitoring to determine whether treatment should continue. Nausea, vomiting, itching, constipation, dizziness, drowsiness, etc. may occur when taking this medicine; closely monitor the patient's response and adjust treatment appropriately. Older adults: Administer the usual adult dose. However, since the elimination half-life of tramadol increased by 17% when administered orally to older adults aged 75 years and older, administer this medicine at intervals of at least 12 hours. Patients with renal impairment: The safety and efficacy of this medicine in patients with renal impairment have not been established; therefore, its use is not recommended. Patients with hepatic impairment: The safety and efficacy of this medicine in patients with hepatic impairment have not been established; therefore, its use is not recommended.

Precautions

This medication should be discussed with a doctor or pharmacist before use by individuals who regularly consume more than three drinks of alcohol per day, as it can pose a risk of liver damage when taken with alcohol. If a rash or hypersensitivity reaction occurs during treatment, discontinue use immediately and consult a doctor, as severe skin reactions can occur rarely. Tramadol, one of the components of this medication, may increase the risk of seizures if taken in doses exceeding the recommended amount or with certain medications, particularly antidepressants or other opioids. In patients with severe respiratory diseases, this medication can cause respiratory depression that may threaten life, so it should be administered in an environment with appropriate equipment. Taking this medication with alcohol or central nervous system depressants can cause severe drowsiness, respiratory depression, and coma, so co-administration should be avoided or used with extreme caution. Patients with head injuries or brain disorders should be cautious, as this medication may increase intracranial pressure during use. This drug can cause dependencies similar to morphine, so careful consideration of dependence risk is necessary with long-term use. Patients with impaired liver function may experience a risk of liver damage due to the acetaminophen component, so consultation with a doctor is essential before use. Especially for individuals with a rapid-acting form of the enzyme CYP2D6, the concentration of the active ingredient in this medication may increase, thus elevating the risk of respiratory depression. This medication is not to be given to children under 12 years old or to adolescents under 18 years old who have undergone tonsillectomy and adenoidectomy, as life-threatening respiratory depression may occur in this age group. Rarely, during treatment, hyponatremia, which is a decrease in blood sodium levels, may occur; therefore, elderly patients or those with risk factors should be monitored closely for symptoms. This drug is not to be used in patients with hypersensitivity to its components, those with central nervous system drug dependence, severe respiratory depression, head injuries, those taking MAO inhibitors, or those with severe liver or kidney impairment. Ensure the recommended dosage is not exceeded, and avoid combining with other tramadol or acetaminophen-containing products for safety. Sudden discontinuation during treatment can lead to withdrawal symptoms, so doses should be tapered off gradually per doctor's instructions. Women who are pregnant or may become pregnant must carefully consider the risk and benefits of administering this medication, and breastfeeding women should avoid using it. Caution is required while driving or operating machinery, as drowsiness or dizziness may occur with this medication. In case of overdose, immediate emergency treatment is required as it may lead to severe respiratory depression or liver damage; appropriate treatment must be provided according to doctor's orders.

Side effects

Liver damage, acute generalized exanthematous pustulosis, Stevens-Johnson syndrome, toxic epidermal necrolysis, seizures, anaphylactic reactions, respiratory depression, deep sedation, coma, weakness, fatigue, flushing, chest pain, rigidity, syncope, withdrawal symptoms, hypertension, worsening hypertension, hypotension, arrhythmia, palpitations, tachycardia, vertigo, headache, tremors, ataxia, convulsions, hypertonia, migraine, worsening migraine, involuntary muscle contractions, paresthesia, stupor, dizziness, abdominal pain, constipation, diarrhea, dyspepsia, flatulence, xerostomia, nausea, vomiting, dysphagia, bloody stools, tongue swelling, decreased appetite, anxiety, confusion, euphoria, insomnia, nervous irritability, drowsiness, forgetfulness, depersonalization, depression, drug abuse, dependence, emotional instability, hallucinations, erectile dysfunction, nightmares, abnormal thinking, anemia, dyspnea, proteinuria, urinary disturbances, oliguria, urinary retention, pruritus, rash, sweating, urticaria, abnormal liver function, weight loss, tinnitus, abnormal vision, chills, vasodilation, orthostatic hypotension, bradycardia, collapse, myocardial ischemia, pulmonary edema, respiratory symptoms, bronchospasm, wheezing, angioedema, allergic reactions, anaphylaxis, Stevens-Johnson syndrome, changes in appetite, muscle weakness, respiratory depression, cognitive dysfunction, difficulty concentrating, suicidal tendencies, hepatitis, liver failure, gastrointestinal bleeding, changes in emotions, changes in activity, changes in cognition, changes in sensory abilities, prolonged prothrombin time, alteration of warfarin effect, serotonin syndrome, worsening asthma, withdrawal symptoms, delirium, mydriasis, myosis, speech impairment, movement disorders, hypoglycemia, hyponatremia, syndrome of inappropriate antidiuretic hormone secretion, thrombocytopenia, agranulocytosis, hypoprothrombinemia, high anion gap metabolic acidosis, weakness, fever, edema, rigidity, syncope, congestive heart failure, dizziness, stupor, respiratory distress, bronchitis, hematuria, dark urine, anuria, urinary retention, urinary incontinence, upper abdominal pain, peptic ulcer, belching, peripheral edema, pallor, blood pressure fluctuations, cough, rhinorrhea, elevated blood pressure, palpitations, irregular menstruation, breast cancer, injury, stupor, migraine, speech impairment, loss of consciousness, recurrence of myocardial infarction, hypotension, confusion, multiple organ failure, deliberate overdose, heartburn, acute gastritis, cold, upper respiratory tract infection, systemic weakness, motion sickness, lethargy, gastrointestinal bleeding, elevated cholesterol, hip pain, thigh pain, allergic rhinitis, nasal bleeding, progression of bile duct cancer, foreign body sensation in the eye, progression of liver cancer, paralytic ileus, cholecystitis, increased salivation, progression of rectal cancer, progression of esophageal cancer, drowsiness, insomnia, nervous irritability, hallucinations, depersonalization, reduced hemoglobin, reduced red blood cells, reduced white blood cells, increased white blood cells, reduced platelets, palpitations, aortic stenosis, chest discomfort, headache, dizziness, worsening migraine, involuntary muscle contractions, hypertonia, tremors, paresthesia, convulsions, dyspnea, asthma, respiratory distress, cough, bronchitis, urinary disturbances, urinary retention, frequent urination, abnormal kidney function tests, oliguria, pruritus, rash, increased sweating, urticaria, dry mouth, diarrhea, dysphagia, flatulence, tongue swelling, hiccups, withdrawal symptoms, panic attacks, severe anxiety, hallucinations, paresthesia, tinnitus, abnormal central nervous system reactions, respiratory depression, somnolence, coma, cardiac arrest, QT prolongation, liver failure, renal tubular necrosis, hypoglycemia, coagulopathy, anxiety, sweating, rigidity, pain, diarrhea, upper respiratory syndrome, purring, excitement, hyperactivity, symptoms of adrenal insufficiency, opioid-induced hyperalgesia, withdrawal syndrome, excessive sedation

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air or moisture, so it must be stored in a tightly sealed container. Additionally, it is recommended to store it at room temperature, specifically between 1 to 30 degrees Celsius, avoiding extreme heat or cold.

Appearance and packaging

Appearance

Pale yellow oblong film-coated extended release tablet

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.